Inflammatory Bowel Diseases (IBD ), such as Crohn's disease and Ulcerative Colitis, are chronic conditions marked by gastrointestinal inflammation, significantly impacting quality of life. While conventional treatments include medications and surgery, scientific research continues to highlight the benefits of Hyperbaric Oxygenation (HBOT ) as a non-invasive approach to managing IBD symptoms.
During a HBOT session, increased pressure facilitates enhanced oxygen absorption, reducing inflammation and positively affecting tissue repair, both crucial for alleviating IBD symptoms. By curbing inflammatory responses, HBOT reduces pain, discomfort, and the risk of complications, improving overall quality of life.
Scientific studies, like a 2015 Journal of Inflammation publication, emphasise HBOT's positive impact on intestinal wound healing.
IBD often leads to damage and ulceration of the intestinal mucosa. Hyperbaric oxygen promotes tissue healing and repair by stimulating the production of growth factors and collagen. Improved tissue integrity can contribute to the overall management of IBD symptoms. Furthermore, a 2021 study published in Gastroenterology Research and Practice showed that 82.5% of study participants with IBD complications such as fistulas achieved full healing following sessions of hyperbaric oxygenation.
HBOT's creation of an oxygen-rich environment inhibits bacteria growth, benefiting IBD patients susceptible to gut dysbiosis. This promotes a healthier gut microbiome, enhancing the immune system. The combined anti-inflammatory, healing, and antibacterial effects position HBOT as an appealing adjunctive treatment for conditions such as Crohn's disease and Ulcerative Colitis.
For more insights into how HBOT can benefit you, contact OxyGeneration at 091-394444 or email [email protected].
